ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Amgen Will Cut Jobs, Close Labs And Plants

by Michael McCoy
August 4, 2014 | APPEARED IN VOLUME 92, ISSUE 31

Amgen, the world’s largest biotech company, will eliminate up to 2,900 jobs, as much as 15% of its workforce, as part of a plan to cut costs and focus on the launch of new drugs. The cuts will take place through 2015, primarily in the U.S. The company will close R&D facilities in Seattle and Bothell, Wash., and manufacturing sites in Boulder and Longmont, Colo. It will scale back at its Thousand Oaks, Calif., headquarters. At the same time, the firm says it will expand its presence in the biotech hubs of Cambridge, Mass., and South San Francisco. The company revealed the cuts while announcing a 26% improvement in second-quarter earnings.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment